Micellae Delivery Systems Appoints Dr. Andrew Kerklaan as CEO
Micellae is pleased to announce the appointment of Dr. Andrew Kerklaan as the Company’s new Chief Executive Officer.
Ground-breaking Technology by Micellae, a University of Toronto Spinout, Set to Revolutionize Cannabinoid Delivery
TORONTO, Aug 4, 2021— Micellae Delivery Systems Inc. (“Micellae”) today announced the launch of its breakthrough drug delivery technology, O2W, the fastest oral bioavailability-enhancing formulation.